Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.1450 (1.78%) ($9.1450 - $9.1450) on Wed. May. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.86% (three month average) | RSI | 37 | Latest Price | $9.1450(1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(63%) IBB(50%) IWC(49%) IWO(45%) IWM(44%) | Factors Impacting EDIT price | EDIT will decline at least -2.43% in a week (0% probabilities). IGOV(-15%) TBT(-12%) UNG(-8%) UUP(-7%) VIXM(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.43% (StdDev 4.86%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $9.44 | 5 Day Moving Average | $9.16(-0.16%) | 10 Day Moving Average | $9.33(-1.98%) | 20 Day Moving Average | $9.44(-3.13%) | To recent high | -11.4% | To recent low | 43.9% | Market Cap | $568m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |